Table 1.
Clinical and hormonal characteristics of assigned female at birth transgender people (N = 18) before gender affirmation surgery.
| Clinical features | ||
|---|---|---|
| Parameter | Mean (range) | Reference values |
| Age, years | 26.6 ± 5.5 (20–40) | NA |
| Weight, kg | 59.6 ± 5.2 (45–65) | NA |
| Height, m | 1.6 ± 0.1 (1.5–1.9) | NA |
| BMI, kg/m2 | 22.5 ± 2.6 (16.8–25.0) | 20.0–25.0 |
| FSH, U/l | 5.6 ± 2.4 (1.2–9.2) | 1.7–8.0 |
| LH, U/l | 3.5 ± 2.6 (0.1–9.5) | 1.5–7.5 |
| Oestradiol, pg/ml | 45.5 ± 7.8 (34.0–59.0) | 10.0–41.0 |
| Total testosterone, ng/ml | 698.5 ± 309.3 (309.0–1224.0) | 275.0–850.0 |
| SHBG, nmol/l | 32.5 ± 15.3 (15.7–64.2) | 25.0–96.0 |
| Androstenedione, ng/dl | 260.8 ± 58.1 (171.0–310.0) | 50.0–250.0 |
| AMH, ng/ml* | 2.2 ± 0.5 (1.4–3.1) | 1.0–4.5 |
Acronyms: BMI body mass index, FSH follicle-stimulating hormone, LH, luteinizing hormone, TT total testosterone, SHBG sex hormone binding globulin, NA not applicable
*n = 18; anti-Müllerian hormone (AMH) was available for 7 people